Scientific Program

검색
Session VII (C).
Satellite Symposium I (A). Room A
(Crystal Ballroom 3)
Date & Time November 6 (Thu), 08:30-09:10
Chair(s) Young Joo Min (Ulsan Univ., Korea)
Speaker
08:30-09:10
Evolving paradigm of ALK+ mNSCLC patient treatment with Lorlatinib

Jang Ho Cho (Gachon Univ., Korea)

Session VII (C).
Session I (A). Lung cancer and risk factors Room A
(Crystal Ballroom 3)
Date & Time November 6 (Thu), 09:20-10:20
Chair(s) Sei-Hoon Yang (Wonkwang Univ., Korea)
Speaker
09:20-09:40
Update on the smoking cessation at lung examination collaboration trials

Joo Hun Park (Ajou Univ., Korea)

09:40-10:00
Smoking and lung cancer: An epidemiologic perspective on causality

Yongho Jee (Ewha Womans Univ., Korea)

10:00-10:20
Climate change-fueled natural hazards and the impacts on lung cancer care

Roselle De Guzman (Manila Central University-FDT Medical Foundation Hospital, Philippines)

Session VII (C).
Session II (A). Partnering for life: Creating a seamless journey together Room A
(Crystal Ballroom 3)
Date & Time November 6 (Thu), 10:35-11:35
Chair(s) Si Yeol Song (Univ. of Ulsan, Korea),
Jeong Eun Lee (Chungnam National Univ., Korea)
Speaker
10:35-10:55
Educate, empower, engage: Underscoring the value of continuity of care

Thomas Newsom-Davis (Chelsea & Westminster Hospital, UK)

10:55-11:15
Toward timely integration of palliative care: Current status of palliative care and advance care planning in Korea

Yu Jung Kim (Seoul National Univ., Korea)

11:15-11:35
The heart of care: Empowering lung cancer patients through oncology nursing support

Mary Duffy (Peter MacCallum Cancer Centre, Australia)

Session VII (C).
Plenary Session I. Room A+B+C
(Crystal Ballroom 1+2+3)
Date & Time November 6 (Thu), 14:10-14:50
Chair(s) Jin-Hyoung Kang (The Catholic Univ. of Korea, Korea)
Speaker
14:10-14:50
New promises and challenges in the treatment of advanced non-oncogene addicted NSCLC

Solange Peters (Centre Hospitalier Universitaire Vaudois, Switzerland)

Session VII (C).
Luncheon Symposium I. Room A+B+C
(Crystal Ballroom 1+2+3)
Date & Time November 6 (Thu), 11:50-12:30
Chair(s) Ji-Youn Han (National Cancer Center, Korea)
Speaker
11:50-12:30
FLAURA2: Advancing first-line therapy for patients with EGFRm NSCLC

Gyeong-Won Lee (Gyeongsang National Univ., Korea)

Session VII (C).
Session III (A). Thymic epithelial tumors: Multidisciplinary approach Room A
(Crystal Ballroom 3)
Date & Time November 6 (Thu), 12:50-13:50
Chair(s) Jin Mo Goo (Seoul National Univ., Korea),
Sung Ho Moon (National Cancer Center, Korea)
Speaker
12:50-13:05
Imaging diagnosis and staging of thymoma

Yura Ahn (Univ. of Ulsan, Korea)

13:05-13:20
Histology-driven surgical strategies in thymic epithelial tumors: Lymph node management and extent of resection in early thymoma

Jae Kwang Yun (Univ. of Ulsan, Korea)

13:20-13:35
Postoperative radiotherapy in thymic tumors: Recent updates or changes

Soo Yoon Sung (The Catholic Univ. of Korea, Korea)

13:35-13:50
Update on systemic therapy in thymic epithelial tumors

Seoyoung Lee (Yonsei Univ., Korea)

Session VII (C).
Session IV (A). The evolving landscape of lung cancer surgery Room A
(Crystal Ballroom 3)
Date & Time November 6 (Thu), 15:10-16:10
Chair(s) Deog Gon Cho (The Catholic Univ. of Korea, Korea),
Wentao Fang (Shanghai Chest Hospital, Shanghai Jiao Tong University , China)
Speaker
15:10-15:25
Wedge resection versus segmentectomy for peripherally-located solid stage IA1–2 NSCLC: Are they oncologically equivalent?

Chang Young Lee (Yonsei Univ., Korea)

15:25-15:40
Knowledge gaps in segmentectomy: What remains to be clarified

Hisashi Saji (Tokyo Medical Univ, Japan)

15:40-15:55
Is surgery more challenging after neoadjuvant chemoimmunotherapy: Myth or Reality?

In Kyu Park (Seoul National Univ., Korea)

15:55-16:10
The evolving role of robotic surgery in lung cancer: Toward less invasive or more advanced

Hyun Koo Kim (Korea Univ., Korea)

Session VII (C).
Satellite Symposium II (A). Room A
(Crystal Ballroom 3)
Date & Time November 6 (Thu), 16:20-17:00
Chair(s) Ki Hyeong Lee (Chungbuk National Univ., Korea)
Speaker
16:20-17:00
MARIPOSA: Setting the new standard in cEGFRm NSCLC

Sun Min Lim (Yonsei Univ., Korea)

Session VII (C).
Session I (B). Advanced radiation techniques and technologies Room B
(Crystal Ballroom 2)
Date & Time November 6 (Thu), 09:20-10:20
Chair(s) Hong-Gyun Wu (Seoul National Univ., Korea),
Jiraporn Setakornnukul (Siriraj Hospital, Mahidol University, Thailand)
Speaker
09:20-09:35
Physical principles and radiobiological characteristics of particle therapy

Yu-Wen Hu (Taipei Veterans General Hospital, Taiwan)

09:35-09:50
Role of particle therapy in early-stage non-small cell lung cancer

Masatoshi Nakamura (University of Tsukuba Hospital, Japan)

09:50-10:05
Particle therapy in locally advanced lung cancer: Current evidence and future perspectives

Yang-Gun Suh (National Cancer Center, Korea)

10:05-10:20
The integration of immunotherapy and particle therapy

Jiraporn Setakornnukul (Siriraj Hospital, Mahidol University, Thailand)

Session VII (C).
Session II (B). Latest trends in biomarker-based precision medicine (KASTT) Room B
(Crystal Ballroom 2)
Date & Time November 6 (Thu), 10:35-11:35
Chair(s) Yoon Soo Chang (Yonsei Univ., Korea),
Yasir Y. Elamin (MD Anderson Cancer Center, USA)
Speaker
10:35-10:50
Targeted therapy in early stage NSCLC

Cheol Kyu Park (Chonnam National Univ., Korea)

10:50-11:05
Circulating tumor DNA (ctDNA) minimal residual disease (MRD) detection in early stage NSCLC

Rina Hui (University of Hong Kong, Hong Kong, China)

11:05-11:20
Longitudinal tracking of ALK-rearranged NSCLC from plasma using circulating tumor RNA and circulating tumor DNA

Yasir Y. Elamin (MD Anderson Cancer Center, USA)

11:20-11:35
The current landscape of liquid biopsy in Korea

Eun Hye Lee (Yonsei Univ., Korea)

Session VII (C).
Session III (B). ADCs: Current controversies Room B
(Crystal Ballroom 2)
Date & Time November 6 (Thu), 12:50-13:50
Chair(s) Jin Seok Ahn (Sungkyunkwan Univ., Korea),
David Planchard (Gustave Roussy Cancer Campus, France)
Speaker
12:50-13:05
The era of antibody drug conjugates in lung cancer: Trick or Threat?

David Planchard (Gustave Roussy Cancer Campus, France)

13:05-13:20
Trop2 ADCs: Is there hope or is all is lost?

Stephanie Saw (National Cancer Centre Singapore, Singapore)

13:20-13:35
Biomarkers for ADCs: IHC and Beyond

Jii Bum Lee (Yonsei Univ., Korea)

13:35-13:50
Emerging ADCs: The next generation

Molly Li (The Chinese University of Hong Kong, Hong Kong, China)

Session VII (C).
Session IV (B). Oncogene Addicted NSCLC: Beyond EGFR and ALK Room B
(Crystal Ballroom 2)
Date & Time November 6 (Thu), 15:10-16:10
Chair(s) Tae Min Kim (Seoul National Univ., Korea),
Ross Soo (National University Hospital, Singapore)
Speaker
15:10-15:30
For ROS1 Fusion NSCLC, Is there still a place for sequential treatment starting with crizotinib?

Aaron Tan (National Cancer Centre Singapore, Singapore)

15:30-15:50
HER2 Mutant NSCLC: ADC vs TKI, Challenges

Ross Soo (National University Hospital, Singapore)

15:50-16:10
KRAS G12C and non-G12C KRAS in lung cancer

Min Hee Hong (Yonsei Univ., Korea)

Session VII (C).
Satellite Symposium II (B). Room B
(Crystal Ballroom 2)
Date & Time November 6 (Thu), 16:20-17:00
Chair(s) Sang-We Kim (Univ. of Ulsan, Korea)
Speaker
16:20-17:00
Surgical game changer: Perioperative immunotherapy in resectable NSCLC

Jae Kwang Yun (Univ. of Ulsan, Korea)

Session VII (C).
Satellite Symposium I (C). Room C
(Crystal Ballroom 1)
Date & Time November 6 (Thu), 08:30-09:10
Chair(s) Taewon Jang (Kosin Univ., Korea)
Speaker
08:30-09:10
Advancing SCLC management with Lurbinectedin clinical experience and IMforte study innovations

Jacob Sands (Dana Farber Cancer Institute, USA)

Session VII (C).
Session I (C). Controversies and future directions of lung cancer screening Room C
(Crystal Ballroom 1)
Date & Time November 6 (Thu), 09:20-10:20
Chair(s) Yeol Kim (National Cancer Center, Korea),
Pan-Chyr Yang (National Taiwan University College of Medicine, Taiwan)
Speaker
09:20-09:35
Optimizing screening eligibility with risk-prediction models and biomarkers

Yeon Wook Kim (Seoul National Univ., Korea)

09:35-09:50
Enhancing benefits by increasing uptake and adherence

Roger Y Kim (University of Pennsylvania, USA)

09:50-10:05
Addressing loco-regional specific needs and feasibility of screening in Asia

Pan-Chyr Yang (National Taiwan University College of Medicine, Taiwan)

10:05-10:20
Lung cancer screening in never smokers: Radiology perspectives

Yeun-Chung Chang (National Taiwan University College of Medicine, Taiwan)

Session VII (C).
Session II (C). Nodule management and early diagnostic strategies Room C
(Crystal Ballroom 1)
Date & Time November 6 (Thu), 10:35-11:35
Chair(s) Seung Hun Jang (Hallym Univ., Korea),
Jianye Chen (National University Hospital, Singapore)
Speaker
10:35-10:50
Novel technologies for nodule risk stratification

Young Sik Park (Seoul National Univ., Korea)

10:50-11:05
Advanced bronchoscopy as a modality of choice for peripheral lung lesions

Fabien Maldonado (Vanderbilt University Medical Center, USA)

11:05-11:20
Management of multifocal lung adenocarcinomas presenting as GGOs with sub-solid changes

Jianye Chen (National University Hospital, Singapore)

11:20-11:35
Advancing Lung Cancer Screening: Detection and Management of Early-Stage Lung Cancer

Jacob Sands (Dana Farber Cancer Institute, USA)

Session VII (C).
Session III (C). Interventional pulmonology Room C
(Crystal Ballroom 1)
Date & Time November 6 (Thu), 12:50-13:50
Chair(s) Young Sik Park (Seoul National Univ., Korea),
Masahide Oki (Nagoya Medical Center, Japan)
Speaker
12:50-13:10
Optimizing tissue acquisition with advanced biopsy techniques

Dongil Park (Chungnam Univ., Korea)

13:10-13:30
Bronchoscopic intervention for central airway obstruction due to lung cancer

Masahide Oki (Nagoya Medical Center, Japan)

13:30-13:50
Management of malignant pleural effusion: From palliation to treatment

David Feller-Kopman (Dartmouth University, USA)

Session VII (C).
Session IV (C). Oral Presentation I Room C
(Crystal Ballroom 1)
Date & Time November 6 (Thu), 15:10-16:10
Chair(s) Sunhee Chang (Inje Univ., Korea),
Hakryul Kim (Wonkwang Univ., Korea)
Speaker
15:10-15:20
Spatial characterization of immunosuppressive microenvironment in patients with PD-L1 Discordant response to pembrolizumab in advanced non-small cell lung cancer

Seong-Eun Kim (Asan Medical Center, Korea)

15:20-15:30
Delta-like ligand 3 (DLL3)-based enrichment enables sensitive and specific detection of circulating tumor cells during immunotherapy in small-cell lung cancer

Hyung-Joo Oh (Chonnam National Univ., Korea)

15:30-15:40
Cereblon (CRBN) suppresses lung adenocarcinoma cell migration and invasion by facilitating the degradation of cystathionine beta-synthase (CBS)

Hyeon-Seung Yoon (Gwangju Institute of Science And Technology, Korea)

15:40-15:50
In vivo CRISPR activation screens reveal drivers of chemoresistance in small cell lung cancer

Jae Heun Chung (Pusan National Univ., Korea)

Session VII (C).
Satellite Symposium II (C). Room C
(Crystal Ballroom 1)
Date & Time November 6 (Thu), 16:20-17:00
Chair(s) Myung-Ju Ahn (Sungkyunkwan Univ., Korea)
Speaker
16:20-17:00
Extending lives, expanding hopes: Tarlatamab in 3L SCLC treatment

Jacob Sands (Dana Farber Cancer Institute, USA)

Session VII (C).
Satellite Symposium III (A). Room A
(Crystal Ballroom 3)
Date & Time November 7 (Fri), 08:20-09:00
Chair(s) Chan Kwon Park (The Catholic Univ. of Korea, Korea)
Speaker
08:20-09:00
From evidence to practice: Brigatinib in the evolving landscape of ALK-Positive NSCLC

Jinyong Kim (Sungkyunkwan Univ., Korea)

Session VII (C).
Session V (A). Novel immunotherapies beyond the PD1 pathway Room A
(Crystal Ballroom 3)
Date & Time November 7 (Fri), 09:10-10:10
Chair(s) Dong-Wan Kim (Seoul National Univ., Korea),
Aaron Elliott Lisberg (University of California, USA)
Speaker
09:10-09:25
Beyond PD-L1 axis inhibition: Where are we going?

Aaron Elliott Lisberg (University of California, USA)

09:25-09:40
Bispecifics and T cell engagers: Fighting against immune desert

Jeongmin Seo (Seoul National Univ., Korea)

09:40-09:55
Combining ICIs with ADCs is the way to go?

Sun Min Lim (Yonsei Univ., Korea)

09:55-10:10
Cellular therapies: Breaking the glass ceiling

Ben Creelan (H. Lee Moffitt Cancer Center & Research Institute, USA)

Session VII (C).
Session VI (A). Challenges during immunotherapy Room A
(Crystal Ballroom 3)
Date & Time November 7 (Fri), 10:25-11:25
Chair(s) Jae Cheol Lee (Univ. of Ulsan., Korea),
Jordi Remon Masip (Institut Gustave Roussy, France)
Speaker
10:25-10:40
Should we exclude immunotherapy in case of advanced NSCLC with oncogenic addiction?

Jordi Remon Masip (Institut Gustave Roussy, France)

10:40-10:55
When can or should anti-PD(L)-1 be stopped in advanced NSCLC?

Jun Hyeok Lim (Inha Univ., Korea)

10:55-11:10
Is it feasible to restart immunotherapy after severe immune-related toxicity?

Jinyong Kim (Sungkyunkwan Univ., Korea)

11:10-11:25
Immunotherapy and brain metastases

Thomas John (Peter MacCallum Cancer Centre, Australia)

Session VII (C).
Luncheon Symposium II. Room A+B+C
(Crystal Ballroom 1+2+3)
Date & Time November 7 (Fri), 11:40-12:20
Chair(s) Young Chul Kim (Chonnam National Univ., Korea)
Speaker
11:40-12:20
What is the future of EGFR-mutant NSCLC treatment: Going solo or combining forces?

Se-Hoon Lee (Sungkyunkwan Univ., Korea)

Session VII (C).
Plenary Session II. Room A+B+C
(Crystal Ballroom 1+2+3)
Date & Time November 7 (Fri), 12:50-13:30
Chair(s) Myung-Ju Ahn (Sungkyunkwan Univ., Korea)
Speaker
12:50-13:30
Current uses and pitfalls of liquid biopsy in NSCLC

Natasha Leighl (Princess Margaret Cancer Centre, Canada)

Session VII (C).
Session VII (A). Surgery in the chemoimmunotherapy era: Global perspectives Room A
(Crystal Ballroom 3)
Date & Time November 7 (Fri), 13:50-14:50
Chair(s) Suk Ki Cho (Seoul National Univ., Korea),
Alessandro Brunelli (St. James's University Hospital, UK)
Speaker
13:50-14:05
Refining surgical boundaries after neoadjuvant therapy in lung cancer

Samina Park (Seoul National Univ., Korea)

14:05-14:20
Optimal nodal management strategies after induction therapy: Scope, challenges, and surgical precision

Mong-Wei Lin (National Taiwan University Hospital, Taiwan)

14:20-14:35
Managing pCR in lung cancer: the evolving role of ctDNA in postoperative strategy

Jeonghwan Youk (Seoul National Univ., Korea)

14:35-14:50
Real-world surgical outcomes after neoadjuvant chemoimmunotherapy: The European experience

Alessandro Brunelli (St. James's University Hospital, UK)

Session VII (C).
Session VIII (A). Stage-Specific considerations and dilemmas Room A
(Crystal Ballroom 3)
Date & Time November 7 (Fri), 15:05-16:05
Chair(s) Gong Yong Jin (Jeonbuk National Univ., Korea),
Jong Ho Cho (Sungkyunkwan Univ., Korea)
Speaker
15:05-15:25
Imaging controversies in lung cancer staging

Won Gi Jeong (Chonnam National Univ., Korea)

15:25-15:45
Systematic EBUS Staging to guide therapy

June hong Ahn (Yeungnam Univ., Korea)

15:45-16:05
Should yp-staging be defined in future editions of the TNM classification system?

Young Tae Kim (Seoul National Univ., Korea)

Session VII (C).
Session V (B). Insights into lung cancer pathology Room B
(Crystal Ballroom 2)
Date & Time November 7 (Fri), 09:10-10:10
Chair(s) Jin-Haeng Chung (Seoul National Univ., Korea),
Mari Mino-Kenudson (Massachusetts General Hospital, USA)
Speaker
09:10-09:30
Intraoperative evaluations of surgical margins/STAS

Mari Mino-Kenudson (Massachusetts General Hospital, USA)

09:30-09:50
Pitfalls in intraoperative evaluations: Benign versus malignant

Dong Hoon Shin (Pusan National Univ., Korea)

09:50-10:10
Tissue is the issue: Maximizing molecular insights from small biopsy and cytology samples

Yeoun Eun Sung (The Catholic Univ. of Korea, Korea)

Session VII (C).
Session VI (B). Unlocking lung cancer: Biological discoveries Room B
(Crystal Ballroom 2)
Date & Time November 7 (Fri), 10:25-11:25
Chair(s) In-Jae Oh (Chonnam National Univ., Korea),
Hyo Sup Shim (Yonsei Univ., Korea)
Speaker
10:25-10:40
Decoding systemic inflammation in lung cancer: Toward precision immuno-oncology

Jae-Ho Cho (Chonnam National Univ., Korea)

10:40-10:55
Integrative proteogenomics identifies non-small cell lung cancer subtypes associated with chromosomal instability and enhanced kinase activity

Joon-Yong An (Korea Univ., Korea)

10:55-11:10
Lepidic adenocarcinoma emerges from alveolar type 1 cells: Rethinking tumorigenesis and clinical implications

Jung-Ki Yoon (Seoul National Univ., Korea)

11:10-11:25
Application of lung cancer organoids in precision medicine

Jinwook Choi (GIST, Korea)

Session VII (C).
Session VII (B). Biology and novel agents in SCLC Room B
(Crystal Ballroom 2)
Date & Time November 7 (Fri), 13:50-14:50
Chair(s) Hye Ryun Kim (Yonsei Univ., Korea),
Wei-Hsun Hsu (National Taiwan University, Taiwan)
Speaker
13:50-14:05
Recent developments in genomics and translational research of SCLC

Esra Akbay (University of Texas Southwestern Medical Center, USA)

14:05-14:20
Rewiring a cold tumor: Immunotherapy strategies for every stage of SCLC in 2025

Wei-Hsun Hsu (National Taiwan University, Taiwan)

14:20-14:35
Rethinking radiotherapy in the era of new standards for SCLC

Young Seob Shin (Univ. of Ulsan, Korea)

14:35-14:50
New drugs in development for SCLC: In search of new hope

Se Hyun Kim (Seoul National Univ., Korea)

Session VII (C).
Session VIII (B). Decoding the tumor microenvironment: A high-tech revolution Room B
(Crystal Ballroom 2)
Date & Time November 7 (Fri), 15:05-16:05
Chair(s) Byoung Chul Cho (Yonsei Univ., Korea),
Woong-Yang Park (GxD Inc. & Sungkyunkwan Univ., Korea)
Speaker
15:05-15:20
Latest trend in Multiplex IHC technology for TME research

Gil-Je Lee (Akoya biosciences, Inc, Korea)

15:20-15:35
Spatial transcriptomic landscape of NSCLC

Yoon Kyung Jeon (Seoul National Univ., Korea)

15:35-15:50
Predicting the TME composition and therapeutic responses using multi-omic technology

Woong-Yang Park (GxD Inc. & Sungkyunkwan Univ., Korea)

15:50-16:05
Integrative single-cell and spatial analyses to understand the generality and specificity of tumor microenvironment

Jong-Eun Park (KAIST, Korea)

Session VII (C).
Closing Symposium. Room A+B+C
(Crystal Ballroom 1+2+3)
Date & Time November 7 (Fri), 16:05-16:45
Chair(s) Jin-Hyoung Kang (The Catholic Univ. of Korea, Korea)
Speaker
16:05-16:45
Perioperative immunotherapy, better outcomes: The emerging standard of care in resectable NSCLC

Hye Ryun Kim (Yonsei Univ., Korea)

Session VII (C).
Satellite Symposium III (C). Room C
(Crystal Ballroom 1)
Date & Time November 7 (Fri), 08:20-09:00
Chair(s) Ji-Youn Han (National Cancer Center, Korea)
Speaker
08:20-09:00
ENHERTU: The first HER2-targeted ADC for HER2-mutant metastatic NSCLC

Jung Seop Eom (Pusan National Univ., Korea)

Session VII (C).
Session V (C). Oral Presentation II Room C
(Crystal Ballroom 1)
Date & Time November 7 (Fri), 09:10-10:00
Chair(s) Sang-Won Um (Sungkyunkwan Univ., Korea),
Jae Hyun Jeon (Seoul National Univ., Korea)
Speaker
09:10-09:20
mpact of quitting smoking at diagnosis on overall survival in lung cancer patients: A comprehensive meta-analysis

Dongwon Park (Hanyang Univ., Korea)

09:20-09:30
Transbronchial mediastinal cryobiopsy for mediastinal lesions: The first single-center experience in South Korea

Min Jee Kim (Asan Medical Center, Korea)

09:30-09:40
Combining deep learning radiomics with clinical data for preoperative prediction of STAS in stage IA lung adenocarcinoma: A multicenter study

Xiaocui Liu (Union Hospital, Tongji Medical College, Huazhong Univ. Of Science And Technology, China)

09:40-09:50
Exosome-based BALF liquid biopsy(ExoBAL)-guided pre-operative lazertinib therapy in potentially resectable EGFR-mutant tumors

In Ae Kim (Konkuk Univ., Korea)

09:50-10:00
Localized defense programs underlie prognostic divergence in GGO and solid lung adenocarcinoma

Sanghyun Han (Chungbuk National Univ., Korea)

Session VII (C).
Session VI (C). Oral Presentation III Room C
(Crystal Ballroom 1)
Date & Time November 7 (Fri), 10:25-11:25
Chair(s) Seong Hoon Yoon (Pusan National Univ., Korea),
Gyeong-Won Lee (Gyeongsang National Univ., Korea)
Speaker
10:25-10:35
Effectiveness and radiation pneumonitis of stereotactic body radiation therapy in high-risk patients with early-stage non-small cell lung cancer

Yoo Kyung Choi (The Catholic Univ. of Korea, Korea)

10:35-10:45
Identification of a novel Golgi Apparatus signature to prognostic stratification and integrative analyses in lung adenocarcinoma

Haoran Li (Sichuan Cancer Hospital, China)

10:45-10:55
Deep learning-driven reconstruction of lineage and immune plasticity trajectories in small cell lung cancer using multi-omics data integration

Rifaldy Fajar (The Integrated Mathematical, Computational, and Data Science for Biomedicine Research Foundation, Indonesia)

10:55-11:05
Tislelizumab vs Pembrolizumab for first-line treatment of non-small cell lung cancer: Literature review of indirect treatment comparisons

Ji-Youn Han (National Cancer Center, Korea)

11:05-11:15
Predictive value of inflammatory biomarkers in EGFR-mutant NSCLC treated with lazertinib: An interim analysis of a prospective real-world study (ORIENT)

Seung Hyeun Lee (Kyung Hee Univ., Korea)

11:15-11:25
Integrated gene expression and network analysis identifies key pathways in small cell lung cancer

Nadyatul Husna (Universitas Andalas, Dr. Reksodiwiryo Military Hospital Padang, Indonesia)

Session VII (C).
Session VII (C). EGFR-Mutant NSCLC: Optimal regimen & rationale Room C
(Crystal Ballroom 1)
Date & Time November 7 (Fri), 13:50-14:50
Chair(s) Jeong-Seon Ryu (Inha Univ., Korea),
Grace Dy (Roswell Park Comprehensive Cancer Center, USA)
Speaker
13:50-14:05
Mono or Combi, is Two really better than One?

Derek De-Rui Huang (National Taiwan University, Taiwan)

14:05-14:20
What should we combine with EGFR Tyrosine Kinase Inhibitors(TKIs): Chemotherapy, antibody or Antibody-Drug Conjugates (ADCs)

Grace Dy (Roswell Park Comprehensive Cancer Center, USA)

14:20-14:35
What is the best sequence for EGFR-Mutant NSCLC? Current options to future options

Lyudmila A. Bazhenova (University of California San Diego, USA)

14:35-14:50
Any new treatment options under development in EGFR-Mutant NSCLC currently not approved?

Byoung Chul Cho (Yonsei Univ., Korea)

Session VII (C).
Session VIII (C). Multi-omics and AI-driven precision in lung cancer Room C
(Crystal Ballroom 1)
Date & Time November 7 (Fri), 15:05-16:05
Chair(s) Ho Yun Lee (Sungkyunkwan Univ., Korea),
Sung Yong Lee (Korea Univ., Korea)
Speaker
15:05-15:20
Recent advances in multimodal and multi-omics biomedical AI for precision oncology

Chan-Young Ock (Lunit, Korea)

15:20-15:35
Multi-omics-based subtyping of NSCLC

Hee Sang Hwang (Univ. of Ulsan, Korea)

15:35-15:50
Multi-omics analysis for discovering therapeutic targets in lung cancer

Ken Asada (National Cancer Center, RIKEN AIP Center, Japan)

15:50-16:05
LLMs under the microscope: Using it right in medical research and practice

Seong Ho Park (National Cancer Center Research Institute, Korea)

Session VII (C).
Joint Symposium with HIRA (Korean) (D). 가이드라인과 급여기준 Room D
(Emerald)
Date & Time November 7 (Fri), 09:10-10:25
Chair(s) 이세훈 (성균관의대),
박인규 (서울의대)
Speaker
09:10-09:30
폐암 가이드라인에 나타난 새로운 치료법

이윤규 (성균관의대)

09:30-09:50
폐암 가이드라인에 나타난 새로운 진단법

김태정 (가톨릭의대)

09:50-10:10
최신 치료법이 건강보험에 반영되는 과정 및 가이드라인의 의미

김국희 (건강보험심사평가원)

10:10-10:25
패널토의: 발전적인 급여 등재 과정을 위한 학회와 심평원의 제언 및 논의

이윤규 (성균관의대), 김태정 (가톨릭의대), 김국희 (건강보험심사평가원)